Lung Cancer Screening (LCS)
Lung Cancer Screening (LCS)
Lung cancer remains one of the most common cancers and the leading causes of cancer-related deaths worldwide.1
"Screen for Life. Breathe with Hope."2, is Canon’s global initiative that aims to improve access to lung cancer screenings, promote awareness of lung cancer, and encourage lung cancer screenings, which can aid in early detection, and ultimately contribute to the reduction of cancer mortality.3
Lung cancer screening faces several critical challenges: low participation rates due to lack of awareness, economic and geographic barriers that limit access to screening, combined with the technical challenge of balancing low radiation dose while maintaining high image quality.
1 Globocan 2020.
2 Canon Medical Strengthens Commitment to Lung Cancer Screening.
3 Oudkerk M. et al | Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives | Nature Reviews Clinical Oncology (2021)
Integrated healthcare and technology in a mobile environment improves accessibility, allowing more individuals in rural areas to receive lung cancer screening CTs.
Meet Allen:
Early Detection: How Lung Cancer Screening CT Saved His Life.
Perspectives Webinar: Unlocking Access to Lung Cancer Screening
Watch our on-demand recording of the roundtable discussion with leading clinical experts, to explore how lung cancer screening implementation and uptake among eligible patients can be improved.
The clinical results, performance and views described are the experience of the clinicians. Results may vary due to clinical setting, patient presentation and other factors.
Lung Cancer Screening at a Glance
Lung cancer screening (LCS) saves lives, but more people need to get screened. Get the big picture on challenges faced in screening and practical solutions in just one glance.
2 Oudkerk M. et al | Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives | Nature Reviews Clinical Oncology (2021)
3 RadiologyInfo.org | Radiation Dose from X-Ray and CT Exams | RadiologyInfo.org. (2022)
Lung Cancer Screening
Early Detection to Save More Lives
Lung cancer is one of the most frequent causes of cancer and the leading cause of cancer death globally.1 When patients present with symptoms, the disease often has already progressed, with limited options remaining for treatment. As a result, prognosis in lung cancer tends to be poor, despite advances in treatment. However, when the disease is detected at an early stage, the chances of survival increase dramatically.2
Consequently, there is a growing interest in lung cancer screening worldwide as the main opportunity to reduce lung cancer mortality.
Canon Medical aims to be your partner in the fight against lung cancer and offers a unique set of lung cancer screening solutions.
“You only have a chance and a good outcome if you detect the cancer at a very, very early stage. And that is the purpose of lung cancer screening.”
Prof. Cornelia M. Schaefer-Prokop, MD, PhD
Radiologist
Appointed member of the Fleischner Society (international group of lung specialists)
Former president of the European Society of Thoracic Imaging (ESTI)
Meander Medical Centre, Amersfoort
Radboud University Medical Center (Radboudumc), Nijmegen the Netherlands
The clinical results, performance and views described here are the experience of the health care providers. Results may vary due to clinical setting, patient presentation and other factors. Many factors could cause the actual results and performance of Canon Medical’s product to be materially different from any of the aforementioned.
Current Challenges
Lung cancer screening faces various challenges that hinder its widespread success. As part of our Made for Life philosophy, Canon Medical is committed to providing support to address these challenges.
Challenge 1:
Low Participation Rate
Many individuals at high risk for lung cancer are often unaware of the potential benefits of screening or may face barriers such as cost, accessibility, or fear of the screening process.
Challenge 2:
Workload and Workflow
Workflow issues, such as managing the influx of screening participants and ensuring timely communication of results, can be a significant burden. Moreover, the repetitive nature of interpreting numerous lung scans can be mentally draining and lead to a loss of enthusiasm.
Challenge 3:
Maintain Clinical Confidence at a Low Dose
Screening participants are typically exposed to repeated CT scans which raises concerns around radiation dose. Lung cancer screening when performed without efficient CT hardware and image reconstruction algorithms, may yield inconclusive or false positive results, leading to additional and costly follow-up procedures, while causing anxiety and stress for patients.
Challenge 4:
Cost-effectiveness
Cost-effectiveness of the program requires a careful balance of the investments in equipment and staff, training, and the number of diagnostic and downstream follow-up procedures versus the benefits of improved health outcomes and less spending on costly therapies in the long-run.
